Sort
82,697 grants matching “vaccine development”
Modeling human hepatotropic infections in complex tissue organoids
$1,086,207Charles M. Rice · Rockefeller University · R01 · FY2013 · DK
Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68
$1,085,889Dinja Oosterhoff · Intravacc B.V. · N01 · FY2023 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$1,085,867Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2025 · AI
Laboratory Support
$1,085,821Wendy Stevens · Wits Health Consortium (Pty), Ltd · U19 · FY2008 · AI
The paradox of flavivirus antigenic non-reciprocity
$1,085,697Thomas C. Friedrich · University Of Wisconsin-Madison · R01 · FY2024 · AI
Ajuvants and Toll-like Receptors in vaccine Development
$1,085,615Univ Of Massachusetts Med Sch Worcester · P01 · FY2004 · AI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
$1,085,403Nicole Doria-Rose · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
RBD recombinant protein-based SARS vaccine for biodefense
$1,085,321Peter J Hotez · Baylor College Of Medicine · R01 · FY2013 · AI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,085,319Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Advanced Mass Spectrometry Facility
$1,085,241David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2011 · DK
Discovery of new anti-bacteremia vaccines for anthrax
$1,085,075Arizona State University-Tempe Campus · U01 · FY2005 · AI
South African Medical Research Council Clinical Trials Unit (MRC CTU)
$1,084,670Gita Ramjee · Medical Research Council Of South Africa · UM1 · FY2018 · AI
Clinical Trials Units for NIAID Networks (UM1)
$1,084,670Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2016 · AI
South African Medical Research Council Clinical Trials Unit (MRC CTU)
$1,084,670Gita Ramjee · Medical Research Council Of South Africa · UM1 · FY2017 · AI
Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic
$1,084,194John Ramunas · Rejuvenation Technologies, Inc. · R44 · FY2024 · TR
PROJECT 2:Structural studies of SOSIP trimers
$1,084,162Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Immunization against filamentous bacteriophages to prevent bacterial infection
$1,084,093Patrick R Secor · University Of Montana · R01 · FY2019 · AI
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications
$1,084,044Massa J. Shoura · Phinomics Inc. · R44 · FY2025 · GM
Pitt-Ohio State Clinical Trials Unit
$1,083,959Sharon Riddler · University Of Pittsburgh At Pittsburgh · UM1 · FY2025 · AI
Development of NHP Models for Infectious Pathogens of Man
$1,083,756Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,083,730Thomas Meek · Texas A&M Agrilife Research · R01 · FY2017 · AI
PRECLINICAL ASSAYS TO PREDICT TETRAVALENT DENGUE VACCINE EFFICACY
$1,083,712Aravinda M De Silva · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$1,083,697John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Preclinical evaluation of a trivalent Marburg vaccine
$1,083,681John Y Dong · Genphar, Inc. · U01 · FY2009 · AI
PATHOGENESIS AND PREVENTION OF AUTOIMMUNE DIABETES
$1,083,518Yale University · P01 · FY2002 · DK